Asset Details
Do you wish to reserve the book?
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Do you wish to request the book?
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
2025
Overview
In this phase 3b, open-label, randomized, controlled trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Aged
/ Anti-Obesity Agents - administration & dosage
/ Anti-Obesity Agents - adverse effects
/ Diabetes mellitus (non-insulin dependent)
/ Diet
/ Female
/ Glucagon-Like Peptide-1 Receptor Agonists - administration & dosage
/ Glucagon-Like Peptide-1 Receptor Agonists - adverse effects
/ Humans
/ Male
/ Obesity
/ Tirzepatide - administration & dosage
/ Tirzepatide - adverse effects
